Home » Clinical Trials » Therapeutic Areas
Therapeutic Areas: Oncology
Disease Category: Cancer/Chemotherapy

Trial Information

A Phase 1 study of Safety, Tolerability and Systemic Absorption of Menadione Topical Lotion for Epidermal-Growth-Factor-Receptor (EGFR) Inhibitor-Associated Rash

This is a research study of an experimental treatment, Menadione Topical Lotion. (This lotion is not approved for use in people. We will compare the study drug lotion to a placebo lotion (lotion that contains no medication).

Hana Biosciences, Inc., the company that is developing Menadione lotion, is the sponsor of this study. A treatment for some types of cancer has a side effect which causes a serious skin rash. The Menadione lotion is being studied to treat this rash. The study is a Phase 1 study which means it is going to look at how safe it is to use this lotion.

For you to be in this study, you must meet the following:

Inclusion Criteria (means that you should be able to say "yes" to the following)

• You are a male or female and at least 18 years old.
• You have cancer and have been prescribed the treatment which may cause rash. You expect to begin this treatment within 14 days.
• Your ECOG performance status of 0-2. ECOG is a way to see how well you feel because of cancer. "0" means you are fully active, "1" means you can do some light work, and "2" means that you can take care of yourself but cannot do any work activity.
• You expect to live for at least 4 months.

Exclusion Criteria (means you would say "no" to the following)

• You are taking any other medicine for cancer and not the kind that may cause rash.
• You are taking more than 2 different types of treatments for cancer.
• You have a disease that will make it difficult to apply the lotion.
• You took the treatment that may cause rash in the last 3 months.
• You have an allergy to the Menadione lotion or any thing in it.

Elizabeth Alvarado
Solano Clinical Research
Located in
Vallejo, CA
Phone: 707-556-1107 ext. 233

View Google Map

DISCLAIMER: This site is run by CenterWatch, a publishing company that focuses on the clinical trials industry. The information provided in this service is designed to help patients find clinical trials that may be of interest to them, and to help patients contact the centers conducting the research. CenterWatch is neither promoting this research nor involved in conducting any of these trials.